Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Kraig Biocraft Laboratories (KBLB) Return on Sales (2016 - 2022)

Kraig Biocraft Laboratories (KBLB) has disclosed Return on Sales for 8 consecutive years, with 12.79% as the latest value for Q4 2022.

  • Quarterly Return on Sales rose 2911826.0% to 12.79% in Q4 2022 from the year-ago period, while the trailing twelve-month figure was 6.31% through Dec 2022, down 1894.0% year-over-year, with the annual reading at 9.79% for FY2025, 337.0% up from the prior year.
  • Return on Sales hit 12.79% in Q4 2022 for Kraig Biocraft Laboratories, up from 10.84% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 40.12% in Q2 2021 to a low of 29105.48% in Q4 2021.
  • Historically, Return on Sales has averaged 2073.7% across 4 years, with a median of 1.12% in 2018.
  • Biggest YoY gain for Return on Sales was 2911826bps in 2022; the steepest drop was -3664bps in 2022.
  • Year by year, Return on Sales stood at 2.91% in 2018, then crashed by -286bps to 11.24% in 2019, then crashed by -258920bps to 29105.48% in 2021, then skyrocketed by 100bps to 12.79% in 2022.
  • Business Quant data shows Return on Sales for KBLB at 12.79% in Q4 2022, 10.84% in Q3 2022, and 3.48% in Q2 2022.